Warner B Swarner, MD | |
6400 Se Lake Rd Ste 325, Milwaukie, OR 97222-2185 | |
(503) 786-1711 | |
(503) 786-9919 |
Full Name | Warner B Swarner |
---|---|
Gender | Male |
Speciality | Psychiatry & Neurology - Psychiatry |
Location | 6400 Se Lake Rd Ste 325, Milwaukie, Oregon |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1922037621 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2084P0800X | Psychiatry & Neurology - Psychiatry | MD11636 (Oregon) | Primary |
Mailing Address | Practice Location Address |
---|---|
Warner B Swarner, MD 6400 Se Lake Rd Ste 325, Milwaukie, OR 97222-2185 Ph: (503) 786-1711 | Warner B Swarner, MD 6400 Se Lake Rd Ste 325, Milwaukie, OR 97222-2185 Ph: (503) 786-1711 |
News Archive
Pre-operative treatment with a combination of the immune checkpoint inhibitors nivolumab and ipilimumab achieves major pathological responses in 100% of early-stage colon cancers with mismatch repair deficiencies, according to results reported at ESMO 2018 from the first exploratory phase II trial to investigate this approach.
Johns Hopkins researchers from the Whiting School of Engineering and the School of Medicine have devised a micro-scale tool - a lab on a chip - designed to mimic the chemical complexities of the brain.
Three studies - one each in Science, Science Translational Medicine, and Science Immunology - reveal the promise of newly engineered bispecific antibodies, including by demonstrating their power against previously inaccessible tumor cell targets for the first time, in two cases.
The cervical cancer vaccine could prevent even more cases of the disease in England than previously thought, UK scientists have found.
KYTHERA Biopharmaceuticals, Inc. today announced that it has received a Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) for a patent application that claims synthetic deoxycholic acid or pharmaceutically acceptable salts thereof, including the synthetic form that is used in ATX-101, a potential first-in-class, injectable drug under clinical investigation for the reduction of submental fat, which commonly presents as an undesirable "double chin."
› Verified 4 days ago
Adeline Plesiu, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 10330 Se 32nd Ave Ste 226, Milwaukie, OR 97222 Phone: 503-513-8020 | |
Dr. Peter Jack Taylor, D.O. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 10202 Se 32nd Ave Ste 701, Milwaukie, OR 97222 Phone: 503-513-1410 | |
Dr. Alan S. Yeo, M.D., MPH Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 6400 Se Lake Rd, Ste 325, Milwaukie, OR 97222 Phone: 541-768-5144 Fax: 541-768-5201 | |
Ronald Lee Spangler, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 10202 Se 32nd Ave Ste 701, Milwaukie, OR 97222 Phone: 503-513-1410 | |
Dr. Philip Manning Bolton, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 6400 Se Lake Rd Ste 325, Milwaukie, OR 97222 Phone: 503-786-1711 Fax: 503-786-9919 | |
Dr. Clyde Mitchell Finch, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 10330 Se 32nd Ave Ste 226, Milwaukie, OR 97222 Phone: 503-215-8020 Fax: 513-215-8025 | |
Steven Paul Goldsmith, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 11630 Se 40th Ave, Suite A, Milwaukie, OR 97222 Phone: 503-505-9265 |